Bibliographic Citation
| - Lebrun Frenay Christine, Edan Gilles, Clanet Michel, Papeix Caroline, Vukusic Sandra, De Sèze Jerome, Debouverie Marc, Gout Olivier, Clavelou Pierre, Defer Gilles, Laplaud David-Axel, Moreau Thibault, Labauge Pierre, Brochet Bruno, Sedel Frédéric, Pelletier Jean. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Multiple Sclerosis Journal, SAGE Publications, 2016, ⟨10.1177/1352458516667568Multiple⟩
- Lebrun Frenay Christine, Edan Gilles, Clanet Michel, Papeix Caroline, Vukusic Sandra, De Sèze Jerome, Debouverie Marc, Gout Olivier, Clavelou Pierre, Defer Gilles, Laplaud David-Axel, Moreau Thibault, Labauge Pierre, Brochet Bruno, Sedel Frédéric, Pelletier Jean. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Multiple Sclerosis Journal, SAGE Publications, 2016, 22 (13), pp.1719--1731. ⟨10.1177/1352458516667568Multiple⟩
|